Knippenberg S - Search Results

1

CDP-choline is not protective in the SOD1-G93A mouse model of ALS.

Knippenberg S, Skripuletz T, Rath KJ, Thau N, Gudi V, Pul R, Körner S, Dengler R, Stangel M, Petri S. Knippenberg S, et al. Amyotroph Lateral Scler Frontotemporal Degener. 2013 May;14(4):284-90. doi: 10.3109/21678421.2012.745569. Epub 2013 Jan 4. Amyotroph Lateral Scler Frontotemporal Degener. 2013. PMID: 23286744

2

Significance of behavioural tests in a transgenic mouse model of amyotrophic lateral sclerosis (ALS).

Knippenberg S, Thau N, Dengler R, Petri S. Knippenberg S, et al. Behav Brain Res. 2010 Nov 12;213(1):82-7. doi: 10.1016/j.bbr.2010.04.042. Epub 2010 May 5. Behav Brain Res. 2010. PMID: 20450936

3

Intraspinal injection of human umbilical cord blood-derived cells is neuroprotective in a transgenic mouse model of amyotrophic lateral sclerosis.

Knippenberg S, Thau N, Schwabe K, Dengler R, Schambach A, Hass R, Petri S. Knippenberg S, et al. Neurodegener Dis. 2012;9(3):107-20. doi: 10.1159/000331327. Epub 2011 Nov 26. Neurodegener Dis. 2012. PMID: 22122965

4

Prolonged survival and milder impairment of motor function in the SOD1 ALS mouse model devoid of fibroblast growth factor 2.

Thau N, Jungnickel J, Knippenberg S, Ratzka A, Dengler R, Petri S, Grothe C. Thau N, et al. Among authors: knippenberg s. Neurobiol Dis. 2012 Aug;47(2):248-57. doi: 10.1016/j.nbd.2012.04.008. Epub 2012 Apr 17. Neurobiol Dis. 2012. PMID: 22542539

5

Intracerebroventricular injection of encapsulated human mesenchymal cells producing glucagon-like peptide 1 prolongs survival in a mouse model of ALS.

Knippenberg S, Thau N, Dengler R, Brinker T, Petri S. Knippenberg S, et al. PLoS One. 2012;7(6):e36857. doi: 10.1371/journal.pone.0036857. Epub 2012 Jun 20. PLoS One. 2012. PMID: 22745655 Free PMC article.

6

Decreased mRNA expression of PGC-1α and PGC-1α-regulated factors in the SOD1G93A ALS mouse model and in human sporadic ALS.

Thau N, Knippenberg S, Körner S, Rath KJ, Dengler R, Petri S. Thau N, et al. Among authors: knippenberg s. J Neuropathol Exp Neurol. 2012 Dec;71(12):1064-74. doi: 10.1097/NEN.0b013e318275df4b. J Neuropathol Exp Neurol. 2012. PMID: 23147503

7

Therapeutic potential of N-acetyl-glucagon-like peptide-1 in primary motor neuron cultures derived from non-transgenic and SOD1-G93A ALS mice.

Sun H, Knippenberg S, Thau N, Ragancokova D, Körner S, Huang D, Dengler R, Döhler K, Petri S. Sun H, et al. Among authors: knippenberg s. Cell Mol Neurobiol. 2013 Apr;33(3):347-57. doi: 10.1007/s10571-012-9900-9. Epub 2012 Dec 28. Cell Mol Neurobiol. 2013. PMID: 23271639

8

Altered expression of DJ-1 and PINK1 in sporadic ALS and in the SOD1(G93A) ALS mouse model.

Knippenberg S, Sipos J, Thau-Habermann N, Körner S, Rath KJ, Dengler R, Petri S. Knippenberg S, et al. J Neuropathol Exp Neurol. 2013 Nov;72(11):1052-61. doi: 10.1097/NEN.0000000000000004. J Neuropathol Exp Neurol. 2013. PMID: 24128678

9

Intraspinal administration of human spinal cord-derived neural progenitor cells in the G93A-SOD1 mouse model of ALS delays symptom progression, prolongs survival and increases expression of endogenous neurotrophic factors.

Knippenberg S, Rath KJ, Böselt S, Thau-Habermann N, Schwarz SC, Dengler R, Wegner F, Petri S. Knippenberg S, et al. J Tissue Eng Regen Med. 2017 Mar;11(3):751-764. doi: 10.1002/term.1972. Epub 2015 Jan 2. J Tissue Eng Regen Med. 2017. PMID: 25641599

10

In vivo MRI of intraspinally injected SPIO-labelled human CD34+ cells in a transgenic mouse model of ALS.

Willenbrock S, Knippenberg S, Meier M, Hass R, Wefstaedt P, Nolte I, Murua Escobar H, Petri S. Willenbrock S, et al. Among authors: knippenberg s. In Vivo. 2012 Jan-Feb;26(1):31-8. In Vivo. 2012. PMID: 22210713

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

78 results

Search Page